Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors

Oncogene

Volumn 19, Issue 8, 2000, Pages 1114-1122

  Bearss, D J ^a   Subler, M A ^b   Hundley, J E ^a   Troyer, D A ^a   Salinas, R A ^b   Windle, J J ^a,b,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

^c CTRC Institute for Drug Development   (United States)

Author keywords

Apoptosis; Doxorubicin; MMTV myc; MMTV ras; p53; Paclitaxel

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; DOXORUBICIN; PACLITAXEL; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CYCLE; CELL CYCLE S PHASE; EXPERIMENTAL NEOPLASM; GENOTYPE; MOUSE; NONHUMAN; ONCOGENE MYC; ONCOGENE RAS; PRIORITY JOURNAL; SALIVARY GLAND TUMOR; TRANSGENIC MOUSE; TUMOR MODEL;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; RODENTIA;

EID: 0034696261     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203275     Document Type: Article

References (43)

1. Arends MJ, McGregor AH, Toft NJ, Brown EJH and Wyllie AH. (1993). Br. J. Cancer, 68, 1127-1133.
2. Barrington RE, Subler MA, Rands E, Omer CA, Miller PJ, Hundley JE, Koester SK, Troyer DA, Bearss DJ, Conner MW, Gibbs JB, Hamilton K, Koblan KS, Mosser SD, O'Neill TJ, Schaber MD, Senderak ET, Windle JJ, Oliff A and Kohl NE. (1998). Mol. Cell. Biol., 18, 85-92.
3. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME and Huang Y. (1993). Leukemia, 7, 563-568.
4. Canman CE, Gilmer TM, Coutts SM and Kastan MB. (1995). Genes Dev., 9, 600-611.
5. Cardiff RD and Muller WJ. (1993). Cancer Surv., 16, 97-113.
6. Cardiff RD and Munn RJ. (1995). Cancer Lett., 90, 13-19.
7. Cardiff RD, Sinn E, Muller W and Leder P. (1991). Am. J. Path., 139, 495-501.
8. Chabner BA. (1993). Anticancer drugs. In: Cancer: principles and practice of oncology. DeVita VT, Hellman S and Rosenberg SA (eds), JB Lippincott Co.: Philadelphia, pp. 325-417.
9. Darzynkiewicz Z. (1994). J. Cell. Biochem., 56, 1-9.
10. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, Pinkel D, Gray J, Bradley A, Medina D and Varmus HE. (1995). Genes Dev., 9, 882-895.
11. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CAJ, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
12. Dorr RT and Von Hoff DD. (1994). Cancer Chemotherapy Handbook, 2nd edn. Appleton and Lange: Norwalk, CT.
13. El-Deiry WS. (1997). Curr. Opin. Onco., 9, 79-87.
14. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
15. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace Jr AJ, Magrath I, Kohn KW and O'Connor PM. (1994). Cancer Res., 54, 5824-5830.
16. Fisher DE. (1994). Cell, 78, 539-542.
17. Gavrieli Y, Sherman Y and Ben-Sasson SA. (1992). J. Cell Biol., 119, 493-501.
18. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
19. Hundley JE, Koester SK, Trover DA, Hilsenbeck SG, Barrington RE and Windle JJ. (1997a). Cancer Res., 57, 600-603.
20. Hundley JE, Koester SK, Troyer DK, Hilsenbeck SG, Subler MA and Windle JJ. (1997b). Mol. Cell. Biol., 17, 723-731.
21. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA. (1994). Curr. Biol., 4, 1-7.
22. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J and Evan G. (1997). Nature, 385, 544-548.
23. Kerr JFR, Winterford CM and Harmon BV. (1994). Cancer, 73, 2013-2026.
24. Klefstrom J, Arighi E, Littlewood T, Jaattela M, Saksela E, Evan GI and Alitalo K. (1997). EMBO J., 16, 7382-7392.
25. Lanni JS, Lowe SW, Licitra EJ, Liu JO and Jacks T. (1997). Proc. Natl. Acad. Sci. USA, 94, 9679-9683.
26. Lin HJ, Eviner V, Prendergast GC and White E. (1995). Mol. Cell. Biol., 15, 4536-4544.
27. Lotem J and Sachs L. (1993). Cell Growth Differ., 4, 41-47.
28. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993). Cell, 74, 957-967.
29. Manfredi JJ and Horwitz SB. (1984). Pharmacol. Ther., 25, 83-125.
30. Milas L, Hunter NR, Kurdoglu B, Mason KA, Meyn RE, Stephens LC and Peters LJ. (1995). Cancer Chemother. Pharmacol., 35, 297-303.
31. Nelson WG and Kastan MB. (1994). Mol. Cell. Biol., 14, 1815-1823.
32. Nooter K, Boersma AW, Oostrum RG, Burger H, Jochemsen AG and Stoter G. (1995). Br. J. Cancer, 71, 556-561.
33. Polyak K, Waldman T, He T-C, Kinzler KW and Vogelstein B. (1996). Genes Dev., 10, 1945-1952.
34. Rowinsky EK and Donehower RC. (1995). New Engl. J. Med., 332, 1004-1014.
35. Shao Z-M, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han Q-X, Ordonez JV, Shroot B and Fontana JA. (1995). Oncogene, 11, 493-504.
36. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R and Leder P. (1987). Cell, 49, 465-475.
37. Skladanowski A and Konopa J. (1993). Biochem. Pharmacol., 46, 375-382.
38. Stewart TA, Pattengale PK and Leder P. (1984). Cell, 38, 627-637.
39. Tewey KM, Rowe TC, Yand L, Halligan BD and Liu LF. (1984). Science, 226, 466.
40. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW and Galloway DA. (1996). Nature Med., 2, 72-79.
41. Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K and Vogelstein B. (1997). Nature Med., 3, 1034-1036.
42. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace Jr AH, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paull KD. (1997). Science, 275, 343-349.
43. Yonish-Rouach E. (1996). Experienta, 52, 1001-1007.